淋巴结阴性-话题@MedSci - 梅斯（MedSci）

#淋巴结阴性#

10篇内容 | 1066人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2054078, encodeId=c08020540e85f, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=NCCN：非手术治疗大肿块（5 -7 cm）、淋巴结阴性的非小细胞肺癌(NSCLC)患者大多不遵循NCCN指南治疗, objectType=article, longId=216800, objectId=78a021680015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78a021680015, replyNumber=0, likeNumber=77, createdTime=2022-04-06, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78a021680015, moduleTitle=NCCN：非手术治疗大肿块（5 -7 cm）、淋巴结阴性的非小细胞肺癌(NSCLC)患者大多不遵循NCCN指南治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=78a021680015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054079, encodeId=15a220540e987, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=Front Oncol：神经侵犯是淋巴结阴性结肠癌的预后指标而不是辅助化疗的预测指标, objectType=article, longId=219539, objectId=0b4e219539a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b4e219539a6, replyNumber=0, likeNumber=63, createdTime=2022-03-10, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b4e219539a6, moduleTitle=Front Oncol：神经侵犯是淋巴结阴性结肠癌的预后指标而不是辅助化疗的预测指标, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0b4e219539a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054077, encodeId=a7e220540e767, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=Lancet：乳腺导管原位癌或淋巴结阴性乳腺癌术后放疗方案的选择, objectType=article, longId=184528, objectId=499218452828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=499218452828, replyNumber=0, likeNumber=74, createdTime=2020-04-08, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=499218452828, moduleTitle=Lancet：乳腺导管原位癌或淋巴结阴性乳腺癌术后放疗方案的选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=499218452828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054076, encodeId=7ffc20540e6c3, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率, objectType=article, longId=145555, objectId=1638145555dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1638145555dc, replyNumber=0, likeNumber=65, createdTime=2018-12-29, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1638145555dc, moduleTitle=CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1638145555dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054075, encodeId=25c120540e5b0, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=Ann Thorac Surg：预测手术完全切除的淋巴结阴性的非小细胞肺癌患者的复发仍具难度, objectType=article, longId=145243, objectId=f5ca14524398, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5ca14524398, replyNumber=0, likeNumber=65, createdTime=2019-07-06, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5ca14524398, moduleTitle=Ann Thorac Surg：预测手术完全切除的淋巴结阴性的非小细胞肺癌患者的复发仍具难度, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f5ca14524398)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054074, encodeId=42b620540e4c0, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=J Thorac Oncol:病灶≤3cm、淋巴结阴性根治性手术肺腺癌的预后因素分析, objectType=article, longId=107462, objectId=725310e462dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=725310e462dd, replyNumber=0, likeNumber=78, createdTime=2017-10-28, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=725310e462dd, moduleTitle=J Thorac Oncol:病灶≤3cm、淋巴结阴性根治性手术肺腺癌的预后因素分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=725310e462dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054073, encodeId=12aa20540e31a, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=CHEST：淋巴结阴性的非小细胞肺癌对内脏胸膜浸润的影响, objectType=article, longId=58230, objectId=3e14582306c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e14582306c, replyNumber=0, likeNumber=70, createdTime=2016-03-28, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e14582306c, moduleTitle=CHEST：淋巴结阴性的非小细胞肺癌对内脏胸膜浸润的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3e14582306c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054071, encodeId=83d120540e19e, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=Ann Surg Oncol：大部分淋巴结阴性乳腺癌可避免腋窝淋巴结摘除, objectType=article, longId=30504, objectId=e08030504e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e08030504e4, replyNumber=0, likeNumber=115, createdTime=2014-10-26, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e08030504e4, moduleTitle=Ann Surg Oncol：大部分淋巴结阴性乳腺癌可避免腋窝淋巴结摘除, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e08030504e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054072, encodeId=a92820540e2a9, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=ATS：纵隔淋巴结阴性的NSCLC可从同期寡转移灶切除中获益, objectType=article, longId=34936, objectId=1c6034936fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c6034936fc, replyNumber=0, likeNumber=63, createdTime=2014-12-26, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c6034936fc, moduleTitle=ATS：纵隔淋巴结阴性的NSCLC可从同期寡转移灶切除中获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1c6034936fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2054070, encodeId=745620540e02f, content=<a href='/topic/show?id=b00e6603262' target=_blank style='color:#2F92EE;'>#淋巴结阴性#</a>, objectTitle=NEJM:辅助多西他赛治疗高危的淋巴结阴性乳腺癌, objectType=article, longId=2327, objectId=f7f5232e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7f5232e03, replyNumber=0, likeNumber=74, createdTime=2011-05-04, rootId=0, userName=ms7899726347904398, userId=fdd32500040, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7f5232e03, moduleTitle=NEJM:辅助多西他赛治疗高危的淋巴结阴性乳腺癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f7f5232e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴结阴性

2020-05-29

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

NCCN：非手术治疗大肿块（5 -7 cm）、淋巴结阴性的非小细胞肺癌(NSCLC)患者大多不遵循NCCN指南治疗

2022-04-06

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

Front Oncol：神经侵犯是淋巴结阴性结肠癌的预后指标而不是辅助化疗的预测指标

2022-03-10

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

Lancet：乳腺导管原位癌或淋巴结阴性乳腺癌术后放疗方案的选择

2020-04-08

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

CCLM：结直肠腺癌中microRNA-28-5p高表达可预测淋巴结阴性患者的短期复发和非转移性疾病患者较低的总体生存率

2018-12-29

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

Ann Thorac Surg：预测手术完全切除的淋巴结阴性的非小细胞肺癌患者的复发仍具难度

2019-07-06

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

J Thorac Oncol:病灶≤3cm、淋巴结阴性根治性手术肺腺癌的预后因素分析

2017-10-28

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

CHEST：淋巴结阴性的非小细胞肺癌对内脏胸膜浸润的影响

2016-03-28

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

Ann Surg Oncol：大部分淋巴结阴性乳腺癌可避免腋窝淋巴结摘除

2014-10-26

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

ATS：纵隔淋巴结阴性的NSCLC可从同期寡转移灶切除中获益

2014-12-26

ms7899726347904398 (审核中...)

前往app查看评论内容

#淋巴结阴性#

NEJM:辅助多西他赛治疗高危的淋巴结阴性乳腺癌

2011-05-04

科室
- - 订阅+
  - 更多科室
工具
服务